Anti-fibrotic effects of nintedanib on lung fibroblasts derived from patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)

Audrey Joannes(École des Hautes Études en Santé Publique), Laurent Vernhet(École des Hautes Études en Santé Publique)
Pulmonary Pharmacology & Therapeutics
November 15, 2023
Cited by 14


Related Papers